As of 1:53pm ET
| -0.16 / -1.34%|
The 7 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 25.00, with a high estimate of 29.00 and a low estimate of 14.00. The median estimate represents a +112.40% increase from the last price of 11.77.
The current consensus among 7 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.